Skip to main content
. Author manuscript; available in PMC: 2015 May 19.
Published in final edited form as: Macromol Biosci. 2014 Aug 8;14(11):1569–1579. doi: 10.1002/mabi.201400220

Table 3.

Loss of dry mass, release of human dentin collagen peptides and hydroxyproline (Hyp)-release into a simulated body fluid (SBF) over a 30 day period. Detected on an untreated control and on two impregnation concentrations of DDA-X-PMOx37-AMA 7 (5.0 and 15.0 wt%). N = 10 individual beams in each group.

treatments loss of dry mass

[wt%]		 inhibition

[%]		 hydroxyproline release
[µg·mg−1], dry mass [%], inhibition
control (no inhibitor) −16.16 ± 2.54a 0 10.43 ± 1.89 A 0
5.0 wt% −6.00 ± 2.63 b 62.9 0.33 ± 0.12 B 96.8
15.0 wt% −4.77 ± 1.70 b 70.5 0.22 ± 0.12 B 97.9